Buscar resultados de ensayos clínicos
Neoplasms, Basal Cell - 16 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial Condición:
|
| Completed |
Nombre del estudio: Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma Condición: Pilomatrixoma Fecha: 2008-07-11 |
| Completed |
Nombre del estudio: Clinical Trial Comparing Tissue Adhesive Vs. Absorbable Suture Vs. Non-Absorbable Suture Condición:
Fecha: 2006-02-15 Intervenciones: Device: standard suture (5-0 prolene), topical skin adhesive (dermabond), absorbable suture (5-0 Chromic gut) |
| Not yet recruiting |
Nombre del estudio: Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma Condición: Basal Cell Carcinoma Fecha: 2016-12-26 Intervenciones: Drug: Vismodegib 1 capsule (150 mg vismodegib) taken once daily for a maximum of 12 weeks. |
| Completed |
Nombre del estudio: Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions Condición: Metastatic Basal Cell Carcinoma Fecha: 2016-04-24 |
| Completed |
Nombre del estudio: Topical Itraconazole in Treating Patients With Basal Cell Cancer Condición: Skin Basal Cell Carcinoma Fecha: 2016-03-31 Intervenciones:
|
| Not yet recruiting |
Nombre del estudio: Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer Condición: Skin Basal Cell Carcinoma Fecha: 2016-03-01 Intervenciones:
|
| Recruiting |
Nombre del estudio: Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer Condición: Skin Basal Cell Carcinoma Fecha: 2016-02-12 Intervenciones:
|
| Completed |
Nombre del estudio: Observational Study to Determine the Effectiveness and Safety of Vismodegib in Patients With Locally Advanced Basal Cell Carcinoma (laBCC) Condición: Locally Advanced Basal Cell Carcinoma Fecha: 2016-02-02 Intervenciones: Drug: Vismodegib Dosing of Vismodegib in accordance with local clinical practice and local labeling |
| Active, not recruiting |
Nombre del estudio: Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) Condición: Basal Cell Carcinoma Fecha: 2016-01-20 Intervenciones: Drug: ERIVEDGE Other Name: VISMODEGIB |